Study of Epratuzumab in Systemic Lupus Erythematosus (SLE)

Stopped early · Phase 3 · Has a placebo group

Conditions studied: Systemic Lupus Erythematosus

In brief

The purpose of this study is to evaluate the safety and efficacy of Epratuzumab with standard treatments for patients with SLE.

Key facts

Study ID

NCT00383214

Run by

UCB Pharma

People needed

54

Starts

2005-05-01

Expected to finish

2007-03-01

Last updated by the study team

2012-06-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• +ANA at screening
• BILAG Index B Level Activity in at least 2 body systems/organs
• Has SLE by ACR revised criteria (meets,<4 criteria)

You may not qualify if…

• Active Severe Lupus as defined by BILAG Index Level A in any body system or organ.
• Allergy to human antibodies or Murine.

Where it is running

• Study site — Tucson, Arizona, United States
• Study site — Los Angeles, California, United States
• Study site — Upland, California, United States
• Study site — Colorado Springs, Colorado, United States
• Study site — Denver, Colorado, United States
• Study site — Farmington, Connecticut, United States
• Study site — Washington D.C., District of Columbia, United States
• Study site — Aventura, Florida, United States
• Study site — Chicago, Illinois, United States
• Study site — Baltimore, Maryland, United States
• Study site — New York, New York, United States
• Study site — Plainview, New York, United States
• Study site — Rochester, New York, United States
• Study site — Syracuse, New York, United States
• Study site — The Bronx, New York, United States
• Study site — Durham, North Carolina, United States
• Study site — Winston-Salem, North Carolina, United States
• Study site — Gallipolis, Ohio, United States
• Study site — Tulsa, Oklahoma, United States
• Study site — Philadelphia, Pennsylvania, United States
• Study site — Charleston, South Carolina, United States
• Study site — Dallas, Texas, United States
• Study site — Arlington, Virginia, United States
• Study site — Edmonds, Washington, United States
• Study site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.